Study Evaluating AGG-523 in Subjects With Osteoarthritis

First posted Jan 29, 2007

Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement

2 participants · First posted Mar 30, 2007

A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

First posted Feb 13, 2007

AGG-523

C₂₈H₂₉FN₂O₄

Tanespimycin

C₃₁H₄₃N₃O₈

TMC Ag3/Ag5 combo

INCOME AMG RTS25OCTD

AGP, LLC

United States

Siemens AG

Novel Nanoparticle Therapy Agg-CLNP Shows Promise for Preventing Rheumatoid Arthritis and Reducing Flares

Valerio Therapeutics to Acquire Etherna Immunotherapies in €30M Deal, Creating Fully Integrated RNA Medicines Company

Uterine Aging May Reduce Donor Egg Pregnancy Success After Age 49, Landmark Study Finds